SPY335.57+1.00 0.30%
DIA278.14+3.52 1.28%
IXIC10,968.36-42.63 -0.39%

OncoCyte shares are trading lower after the company reported worse-than-expected Q2 EPS results. UPDATE: Shares have since reversed.

Benzinga · -